
Acoustic MedSystems Inc (AKA: Acoustx) Profile last edited on: 3/13/2020
CAGE: 46JF6
UEI: HKU8TL9TT2R5
Business Identifier: Ultrasound catheters for targeted thermal ablation of tumors Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 13
County: Champaign
Congr. District: 13
County: Champaign
Public Profile
Acoustic MedSystems, Inc. (AMS) is structured around developing interventional devices and systems for treatment of localized disease - specializing in applications of treatment planning and image-guided interventions using ablative therapy technologies and radiation therapy. Using core competencies of firm's principals in interventional image guidance, ultrasound ablation technology, treatment planning / dose optimization, and clinical systems integration to develop minimally invasive devices and integrated systems for treatment of localized cancers and other disorders, products of focus are ablation/radiation treatment planning, delivery guidance software and systems, and high intensity needle-based and catheter-based interventional devices for thermal ablative therapy. These devices create highly conformal (shape, volume) controlled high-intensity ultrasound energy delivery for customized patient-specific treatment.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
20-24Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2022 | 2 | NIH | $2,445,371 | |
Project Title: Image-Guided Transurethral Hifu for Genitourinary Therapy | ||||
2019 | 1 | NIH | $270,494 | |
Project Title: Minimally-Invasive Catheter-Based Ultrasound for Precision Tumor Ablation in Lung | ||||
2018 | 1 | NIH | $230,149 | |
Project Title: Soft-Focused HIFU Treatment of Common Peroneal Nerve Injury | ||||
2015 | 2 | NIH | $1,437,909 | |
Project Title: Image-Guided High-Intensity Interstitial Ultrasound for Thermal Ablation of Uteri | ||||
2013 | 1 | NIH | $177,408 | |
Project Title: Integrated Photoacoustic Ultrasound Real-Time Imaging For Brachytherapy Treatment |
Key People / Management
Everette C Burdette -- President and CEO
Chris John Diederich -- Chief Scientific Officer
Gabor Fichtinger
Lance Frith
Kenneth Hughes -- Business Development Officer
Chris John Diederich -- Chief Scientific Officer
Gabor Fichtinger
Lance Frith
Kenneth Hughes -- Business Development Officer
Company News
There are no news available.